TKT and glioblastoma: Novel TK inhibitors with pyrazolo[3,4-d]pyrimidine scaffold are ATP-competitive TK inhibitors with good efficacy regarding the inhibition of SFKs [18,19], and their activity against neuroblastoma and glioblastoma has been demonstrated in vitro and in vivo [20,21,22,23,24,25].